Volume :

3

Issue :

1

Abstract :

Only cancers that start in the liver are called liver cancer (hepatocellular carcinoma). Liver cancer is the third leading cause of cancer death and the fifth most common solid tumor worldwide. Its incidence has increased dramatically in the past few years in all over the world. Despite advances in surgical and nonsurgical therapies in the treatment of liver cancer, a number of controversial issues regarding appropriate screening methods, diagnosis, staging, and management continue to evolve.[1] The aim of this review is to help the practicing Pharm D students, clinical pharmacist and physicians to identify high-risk patients, implement an appropriate screening strategy, order relevant tests to confirm the diagnosis, and formulate an appropriate management plan which include newer treatment options like virus therapy, nano knife, magnetic targeting, therasphere etc.